Skip to main content Skip to footer

Investment Suitability and Loss Assessment Process (November 2012)

In the majority of investment complaints we receive each year about advice-based accounts, investors complain that they received poor advice, their investments or investment strategies were unsuitable and/or that their investments did not perform as they expected. In such "suitability" complaints, investors ask to be compensated for the investment losses they incurred.

In 2011 OBSI issued for public comment a consultation paper detailing our investment suitability and loss assessment process. After considering the feedback received, on May 10, 2012 we issued a second consultation paper detailing a series of proposed changes to our process.

Today, OBSI published the Board of Directors' decision on changes to the methodology and OBSI's response to stakeholder feedback.

There have been numerous steps along the way of what has been a comprehensive process of consultation on OBSI's investment suitability and loss assessment process. OBSI has published two consultation papers; participated in an industry working group; solicited opinions from experts in loss valuation and the law; held three information sessions, one for each of the public, IIROC members and MFDA members; and consulted regularly with securities regulators, industry participants, investor representatives, and OBSI's independent Consumer and Investor Advisory Council. Throughout this process we have found the engagement by our stakeholders and partners to be immensely valuable. For that we extend our appreciation to all involved.

All past documents and stakeholder submissions related to the consultation can be found on our website. Any questions can be directed to Tyler Fleming, Director of Stakeholder Relations and Communications, at publicaffairs@obsi.ca.

Documents

This website uses cookies to enhance usability and provide you with a more personal experience. By using this website, you agree to our use of cookies as explained in our Privacy Policy.